Description
Recombinant monoclonal antibody to CD21L. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma R4/23. This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques.
Target
CD21L
Target Alias Names
Complement receptor type 2, CR2, Complement C3d receptor, Epstein-Barr virus receptor, EBV receptor, CD21
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression